NCT01847833

Brief Summary

The goals of this study are to:

  1. 1.To improve upon and develop new innovative magnetic resonance imaging techniques that refine image quality and enhance performance. Improvements in these areas will have positive implications for medical diagnosis and treatment.
  2. 2.To correlate MRI images with underlying disease pathophysiology in order to ensure that imaging accurately reflects the disease process.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 11, 2013

Completed
4 months until next milestone

First Posted

Study publicly available on registry

May 7, 2013

Completed
8 months until next milestone

Study Start

First participant enrolled

January 1, 2014

Completed
9.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2023

Completed
Last Updated

March 26, 2018

Status Verified

March 1, 2018

Enrollment Period

9.9 years

First QC Date

January 11, 2013

Last Update Submit

March 22, 2018

Conditions

Brain Tumors

Outcome Measures

Primary Outcomes (1)

  • patients alive and progression free at 6 months

    6 months

Study Arms (1)

Patients with brain tumors

Other: MRI scan

Interventions

MRI scanOTHER
Patients with brain tumors

Eligibility Criteria

Age18 Years+
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with brain tumors or tumors affecting the brain.

You may qualify if:

  • Brain Tumor

You may not qualify if:

  • Unable to undergo MRI

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

MGH

Boston, Massachusetts, 02114, United States

RECRUITING

MeSH Terms

Conditions

Brain Neoplasms

Interventions

Magnetic Resonance Spectroscopy

Condition Hierarchy (Ancestors)

Central Nervous System NeoplasmsNervous System NeoplasmsNeoplasms by SiteNeoplasmsBrain DiseasesCentral Nervous System DiseasesNervous System Diseases

Intervention Hierarchy (Ancestors)

Spectrum AnalysisChemistry Techniques, AnalyticalInvestigative Techniques

Central Study Contacts

Elizabeth Gerstner

CONTACT

617-724-8770

Wndy Atkinson

CONTACT

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dr.

Study Record Dates

First Submitted

January 11, 2013

First Posted

May 7, 2013

Study Start

January 1, 2014

Primary Completion

December 1, 2023

Last Updated

March 26, 2018

Record last verified: 2018-03

Locations

US(1)